Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Avoro Capital Advisors LLC has filed 312 SEC EDGAR filings since 13 Feb 2015

SEC filing history

Showing 226-250 of 312 matching filings.

Per page
25
Current page
10
SC 13G/A

TELIGENT, INC.

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

XENON PHARMACEUTICALS, INC.

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

IOVANCE BIOTHERAPEUTICS, INC.

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

FENNEC PHARMACEUTICALS INC.

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

INTEC PHARMA LTD.

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

AMICUS THERAPEUTICS, INC.

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

TG THERAPEUTICS, INC.

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

MIRATI THERAPEUTICS, INC.

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

BIODELIVERY SCIENCES INTERNATIONAL, INC.

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-16573

13F-HR filing

Filing date
14 Nov 2018
Reporting date
30 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-12104

4 filing

Filing date
18 Sep 2018
Reporting date
02 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-16573

13F-HR filing

Filing date
14 Aug 2018
Reporting date
30 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-12104

IMMUNOMEDICS, INC.

Filing date
19 Jun 2018
Reporting date
15 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

IMMUNOMEDICS INC

Filing date
19 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

IMMUNOMEDICS, INC.

Filing date
15 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-12104

IMMUNOMEDICS, INC.

Filing date
15 Jun 2018
Reporting date
15 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-35921

MIRATI THERAPEUTICS, INC.

Filing date
12 Jun 2018
Reporting date
11 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-16573

13F-HR filing

Filing date
15 May 2018
Reporting date
31 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-12104

IMMUNOMEDICS, INC.

Filing date
16 Feb 2018
Reporting date
16 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-16573

13F-HR filing

Filing date
14 Feb 2018
Reporting date
31 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

ONCOBIOLOGICS, INC.

Filing date
12 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

ALIMERA SCIENCES, INC.

Filing date
12 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

FENNEC PHARMACEUTICALS INC.

Filing date
12 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

INTEC PHARMA LTD.

Filing date
12 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

AMICUS THERAPEUTICS, INC.

Filing date
12 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .